Topical sirolimus in the treatment of facial angiofibromas
Main Author: | Resham Vasani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Indian Journal of Drugs in Dermatology |
Online Access: | http://www.ijdd.in/article.asp?issn=2455-3972;year=2018;volume=4;issue=2;spage=49;epage=51;aulast=Vasani |
Similar Items
-
Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient
by: Resham J Vasani
Published: (2015-01-01) -
Topical sirolimus in facial angiofibroma
by: Prachi Chetankumar Gajjar, et al.
Published: (2018-01-01) -
Topical rapamycin (sirolimus) for facial angiofibromas
by: Bhushan Madke
Published: (2013-01-01) -
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex
by: Takashi Hatano, et al.
Published: (2020-06-01) -
Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex
by: Tohru Okanishi, et al.
Published: (2020-01-01)